Cargando…

Efficacy of Autologous Bone Marrow Mononuclear Cell Transplantation Therapy for Type 2 Diabetes Mellitus: An Updated Meta-Analysis

INTRODUCTION: Studies of the effects of stem cell therapy on type 2 diabetes mellitus (T2DM) have not reached consistent results. Our meta-analysis aimed to systematically evaluate the efficacy of autologous bone marrow-derived stem cells (ABM-MNCs) on T2DM. METHODS: We systematically searched PubMe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Xue-Jun, Li, Feng-Ju, He, Yu-Zhuo, Hou, Shu-Fang, Zhu, Hong-Bin, Cheng, Ying, Nan, Zhen, Lin, Xiao-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437223/ https://www.ncbi.nlm.nih.gov/pubmed/30725399 http://dx.doi.org/10.1007/s13300-019-0578-6

Ejemplares similares

Clinical improvement after autologous bone marrow mononuclear cell transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke
por: Sharma, Alok, et al.
Publicado: (2014)

Efficacy of autologous bone marrow mononuclear cell transplantation in dogs with chronic spinal cord injury
por: Tamura, Katsutoshi, et al.
Publicado: (2020)

Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy
por: Mao, Hong, et al.
Publicado: (2019)

Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy – a case report
por: Sharma, Alok, et al.
Publicado: (2014)

Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity
por: Bhansali, Shobhit, et al.
Publicado: (2017)

Granulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice
por: Zhang, Xue-Mei, et al.
Publicado: (2011)

Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke
por: Wagner, Daniel-Christoph, et al.
Publicado: (2012)

Catheter-based transendocardial delivery of autologous bone marrow-derived mononuclear cells in patients listed for heart transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability
por: Sharma, Alok, et al.
Publicado: (2018)

Autologous bone marrow mononuclear cell transplantation in patients with chronic traumatic brain injury- a clinical study
por: Sharma, Alok K., et al.
Publicado: (2020)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Quality of Life (QOL) improvement following catheter-based autologous bone marrow mononuclear cell transplantation (ABM-MCT)
por: Silva, SA, et al.
Publicado: (2003)

Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial
por: Spahr, Laurent, et al.
Publicado: (2013)

Transplantation of autologous bone marrow–derived mononuclear cells into cerebrospinal fluid in a canine model of spinal cord injury
por: Nakamoto, Yuya, et al.
Publicado: (2023)

Autologous bone marrow-derived mononuclear cell therapy in three patients with severe asthma
por: Aguiar, Fabio S., et al.
Publicado: (2020)

Evaluation of the autologous bone marrow mononuclear therapy and functional restoration in the scarred myocardium by imaging analysis
por: Gokhale, Alla Gopala Krishna, et al.
Publicado: (2011)

Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study
por: Sharma, Alok, et al.
Publicado: (2013)

Autologous Pancreatic Islet Transplantation in Human Bone Marrow
por: Maffi, Paola, et al.
Publicado: (2013)

Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina
por: Tuma, Jorge, et al.
Publicado: (2011)

Intrathecal transplantation of autologous bone marrow mononuclear cells in patients with sub-acute and chronic spinal cord injury: An open-label study
por: Sharma, Alok, et al.
Publicado: (2020)

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells
por: Nguyen, Liem Thanh, et al.
Publicado: (2021)

Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Stem Cells in Subacute Ischemic Stroke Patients
por: Ghali, Azza Abass, et al.
Publicado: (2016)

Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial
por: Nguyen, Liem Thanh, et al.
Publicado: (2017)

Outcomes of autologous bone marrow mononuclear cell administration in the treatment of neurologic sequelae in children with spina bifida
por: Nguyen, Liem Thanh, et al.
Publicado: (2023)

Efficacy of Surgery Combined with Autologous Bone Marrow Stromal Cell Transplantation for Treatment of Intracerebral Hemorrhage
por: Zhu, Jianxin, et al.
Publicado: (2015)

PET imaging of microglia using PBR28suv determines therapeutic efficacy of autologous bone marrow mononuclear cells therapy in traumatic brain injury
por: Bedi, Supinder S., et al.
Publicado: (2023)

Effect of heterologous bone marrow mononuclear cell transplantation on midpalatal expansion in rats
por: GUO, JIE, et al.
Publicado: (2015)

Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: A pilot study
por: Prasad, Kameshwar, et al.
Publicado: (2012)

Autologous Bone Marrow Mononuclear Cells in Ischemic Cerebrovascular Accident Paves Way for Neurorestoration: A Case Report
por: Sharma, Alok, et al.
Publicado: (2014)

A Clinical Study of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Patients: A New Frontier
por: Sharma, Alok, et al.
Publicado: (2015)

Effect of IGF-1 and Uncultured Autologous Bone-Marrow-Derived Mononuclear Cells on Repair of Osteochondral Defect in Rabbits
por: Tiwary, Ramesh, et al.
Publicado: (2014)

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
por: Skóra, Jan, et al.
Publicado: (2014)

Serial Cerebral Metabolic Changes in Patients With Ischemic Stroke Treated With Autologous Bone Marrow Derived Mononuclear Cells
por: Haque, Muhammad E., et al.
Publicado: (2019)

Autologous bone-marrow mononuclear stem cell therapy in patients with stroke: a meta-analysis of comparative studies
por: Chumnanvej, Sorayouth, et al.
Publicado: (2020)

Autologous Bone-Marrow vs. Peripheral Blood Mononuclear Cells Therapy for Peripheral Artery Disease in Diabetic Patients
por: Yunir, Em, et al.
Publicado: (2020)

Autologous bone marrow mononuclear cell infusion for liver cirrhosis after the Kasai operation in children with biliary atresia
por: Nguyen, Thanh Liem, et al.
Publicado: (2022)

The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction
por: Jeong, Hyunsuk, et al.
Publicado: (2013)

Immediate and short-term safety of catheter-based autologous bone marrow-derived mononuclear cell transplantation into myocardium of patients with severe ischemic heart failure
por: Dohmann, HF, et al.
Publicado: (2003)

Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients
por: Taguchi, Akihiko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_740l92sjvntakp7fuqjhj69nu1